Novozymes A/S – (NASDAQ:NVZMY) has been given a consensus broker rating score of 3.00 (Hold) from the one analysts that cover the company, Zacks Investment Research reports. One analyst has rated the stock with a hold rating.

Analysts have set a 12-month consensus price target of $50.96 for the company, according to Zacks. Zacks has also given Novozymes A/S – an industry rank of 49 out of 265 based on the ratings given to related companies.

Separately, Zacks Investment Research cut Novozymes A/S – from a “hold” rating to a “sell” rating in a report on Thursday, August 25th.

Novozymes A/S – (NASDAQ:NVZMY) traded down 0.34% during midday trading on Tuesday, reaching $43.55. The company had a trading volume of 2,094 shares. The stock’s 50 day moving average is $44.41 and its 200 day moving average is $46.07. Novozymes A/S – has a one year low of $37.98 and a one year high of $49.55. The company has a market capitalization of $13.08 billion and a PE ratio of 30.26.

About Novozymes A/S –

Novozymes A/S is a Denmark-based biotechnology company engaged in the production and sale of industrial enzymes, microorganisms and biopharmaceutical ingredients. In June 2013, the Company restructured its sales areas within those segments. The Household Care (old Household Care Enzymes) area comprises cleaning solutions, laundry, dishwashing and microorganism sales for cleaning solutions.

5 Day Chart for NASDAQ:NVZMY

Get a free copy of the Zacks research report on Novozymes A/S – (NVZMY)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Novozymes A/S - Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S - and related companies with's FREE daily email newsletter.